As filed with the Securities and Exchange Commission on October 24, 2007
Registration No.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
_________________________________________
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
OCEAN BIO-CHEM, INC.
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
FLORIDA
--------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation or Organization)
59-1564329
--------------------------------------------------------------------------------
(I.R.S. Employer Identification No.)
4041 S. W. 47 Avenue, Fort Lauderdale, Florida 33314
--------------------------------------------------------------------------------
(Address of Principal Executive
Offices) (Zip Code)
--------------------------------------------------------------------------------
(Full Title of the Plans)
Peter G. Dornau, 4041 SW 47 Avenue, Fort Lauderdale, FL 33314
--------------------------------------------------------------------------------
(Name and Address of Agent for Services)
954-587-6280
--------------------------------------------------------------------------------
Telephone Number, Including Area Code, of Agent for Service.
CALCULATION OF REGISTRATION FEE
------------------------------ ------------- ------------------------ ------------------------ ----------------
Title of Each Class of Amount To Be Proposed Maximum Proposed Maximum Amount of
Securities To Be Registered Registered (1) Offering Price Per Share (2) Aggregate Offering Price Registration Fee
------------------------------ ------------- ------------------------ ------------------------ ----------------
Ocean Bio-Chem, Inc.
$.01 per value Common Stock 145,000 $1.80 $261,000 $30.70
------------------------------ ------------- ----------------------- ------------------------ ----------------
(1) This Registration Statement also registers the offer and sale of an
indeterminate number of additional shares of Common Stock of the Registrant that
may be issuable as a result of stock splits, stock dividends, recapitalizations,
mergers, reorganizations, combinations or exchanges of shares or other similar
events.
(2) Estimated solely for the purpose of calculating the amount of the
Registration Fee pursuant to Rule 457, promulgated under the Securities Act of
1933, as amended, and based on the average high and low sales price of the Ocean
Bio-Chem, Inc. Common Stock on October 19, 2007
THIS REGISTRATION STATEMENT SHALL BECOME EFFECTIVE UPON FILING WITH THE
SECURITIES AND EXCHANGE COMMISSION (THE "COMMISSION") IN ACCORDANCE WITH SECTION
8(A) OF THE SECURITIES ACT OF 1933, AS AMENDED, AND RULES 456 AND 462
PROMULGATED THEREUNDER.
PART I
EXPLANATORY NOTE
Ocean Bio-Chem, Inc. ("we," "us" or the "Company") has prepared this
Registration Statement in accordance with the requirements of Form S-8 under the
Securities Act of 1933, as amended (the "Act"), to register shares of Common
Stock, $.01 par value, of the Company issued to employees of the Company
pursuant to the Company's 2002 Incentive Stock Option Plan and 2002
Non-qualified Stock Option Plan (the "Plans").
This Registration Statement contains two parts. The first part contains a
reoffer Prospectus prepared in accordance with the requirements of Part I of
Form S-3 pursuant to Section C of the General Instructions to Form S-8. The
reoffer Prospectus may be used for reofferings and resales on a continuous or
delayed basis in the future of "control securities" which have been or may be
issued pursuant to the Plan to employees of the Company who may be considered
affiliates as defined by Rule 405 under the Act.
The second part contains "Information Required in the Registration
Statement" pursuant to Part II of Form S-8. Pursuant to the Note to Part I of
Form S-8, the information relating to the Plan specified by Part I is not filed
with the Securities and Exchange Commission (the "Commission"), but documents
containing such information have been or will be sent or given to employees and
directors as specified by Rule 428(b)(1). Such document(s) are not being filed
with the Commission but constitute (along with the documents incorporated by
reference into the Registration Statement pursuant to Item 3 of Part II hereof)
a Prospectus that meets the requirements of Section 10(a) of the Act.
PROSPECTUS
Ocean Bio-Chem, Inc.
145,000 Shares
Common Stock
($.01 par value)
----------------------
Certain of our stockholders are using this Prospectus to offer up to
145,000 shares of our Common Stock, $.01 par value (the "Shares") that they
received from us pursuant to the Plans. Some of these stockholders may be
considered our "affiliates," as defined in Rule 405 under the Securities Act of
1933, as amended.
We expect that sales made pursuant to this Prospectus will be made:
-- in broker's transactions;
-- in transactions directly with market makers; or
-- in negotiated sales or otherwise.
The selling stockholders will sell their shares pursuant to a Rule
10b5-1(c) Trading Plan. They will determine when they will sell their Shares,
and in all cases they will sell their Shares at the current market price or at
prices negotiated at the time of the sale. We will not receive any proceeds from
these sales, although we have received cash from the sale of the Shares to
selling shareholders who exercised options received under the Plans to acquire
the Shares. All expenses incurred in connection with the preparation and filing
of this Prospectus and related Registration Statement are being borne by us.
The brokers and dealers that the selling stockholders utilize in selling
these Shares may receive compensation in the form of underwriting discounts,
concessions, or commissions from the sellers or purchasers of the Shares. Any
compensation may exceed customary commissions. The selling stockholders and the
brokers and dealers that they utilize may be deemed to be "underwriters" within
the meaning of the securities laws, and any commissions received and any profits
realized by them on the sale of Shares may be considered to be underwriting
compensation.
The Shares are listed on the NASDAQ under the symbol "OBCI." The last
reported sale price of the Shares as reported on NASDAQ was $1.73 per share on
October 20, 2007.
Our principal executive offices are located at 4041 SW 47 Avenue, Fort
Lauderdale, Florida 33314, our telephone number is (954) 587-6280.
This investment involves risks. See the "Risk Factors" section beginning on
page 9.
2
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of the securities or passed upon the
adequacy or accuracy of this Prospectus. Any representation to the contrary is a
criminal offense.
This Prospectus is dated on October 24, 2007
TABLE OF CONTENTS
Page
Available Information 3
Incorporation of Certain Documents
by Reference 3-4
Risk Factors 4
Our Company 5
Selling Stockholders 5-6
Plan of Distribution 6
Use of Proceeds 6
Expenses 6
Experts 6
Certain Forward-Looking Statements 6-7
This Prospectus contains information concerning the Company, but does not
contain all of the information set forth in the Registration Statement and its
Exhibits, which the Company has filed with the Securities and Exchange
Commission, Washington, D.C., under the Securities Act of 1933, as amended, and
to which reference is made.
No dealer, salesperson or other person has been authorized to give any
information or to make any representation not contained in this Prospectus and,
if given or made, such information or representation must not be relied upon as
having been authorized by the Company. This Prospectus does not constitute an
offer to sell or a solicitation of an offer to buy any of the securities offered
hereby in any jurisdiction to any person to whom it is unlawful to make such
offer in such jurisdiction. Neither the delivery of this Prospectus nor any sale
made under this Prospectus shall under any circumstances, create any implication
that there have not been changes in the affairs of the Company since the date of
this Prospectus.
AVAILABLE INFORMATION
We are subject to the informational requirements of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), and in accordance with the
Exchange Act we are required to file periodic reports, proxy statements and
other information with the Securities and Exchange Commission (the
"Commission"). Such reports, proxy statements and other information filed by us
can be inspected and copied at the public reference facilities maintained by the
Commission at 450 Fifth Street, N.W., Room 1024, Washington, D.C. 20549 at the
prescribed rates. The Commission also maintains a site on the World Wide Web
that contains reports, proxy and information statements and other information
regarding registrants that file electronically. The address of that site is
http://www.sec.gov. The public may obtain information on the operation of the
Public Reference Room by calling 1-800-SEC-0330.
This Prospectus omits certain of the information contained in the
Registration Statement of which this Prospectus is a part (the "Registration
Statement"), covering Shares offered under this Prospectus. Pursuant to the
Securities Act, the Registration Statement is on file with the Commission. For
further information with respect to us and the Shares offered under this
Prospectus, reference is made to the Registration Statement, including the
exhibits incorporated therein by reference or filed therewith. Statements
contained in this Prospectus concerning the provisions of any document are not
necessarily complete and, in each instance, reference is made to the copy of
such document filed as an exhibit or incorporated by reference to the
Registration Statement or elsewhere. The Registration Statement and the exhibits
may be inspected without charge at the offices of the Commission or copies
obtained at prescribed rates from the public reference section of the Commission
at the address set forth above.
The Company will provide to each person, including any beneficial owner, to
whom a Prospectus is delivered, a copy of any or all of the information that is
incorporated by reference into the Prospectus but not delivered with the
Prospectus, upon written or oral request, at no cost to the person requesting
it. Please direct all requests to Mr. Jeffrey S. Barocas at Ocean Bio-Chem,
Inc., 4041 SW 47 Avenue, Fort Lauderdale, Florida 33314,
You should rely only on the information contained in or incorporated by
reference into this Prospectus. We have not authorized anyone to provide you
with information different from that contained in and specifically incorporated
by reference into this Prospectus. This Prospectus is an offer to sell, or a
solicitation of offer to buy shares of Common Stock only in jurisdictions where
offers and sales are permitted. The information contained in this Prospectus is
accurate only as of the date of this Prospectus, regardless of the time of
delivery of this Prospectus or any sale of Common Stock.
3
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The following documents filed by us with the Securities and Exchange
Commission (the "Commission") are incorporated herein by reference as of their
respective dates of filing and shall be deemed to be a part hereof:
1. Our Annual Report on Form 10-K for the year ended December 31, 2006;
2. Our Proxy Statement for the Annual Meeting of Shareholders held on
August 3, 2007.
3. Our quarterly reports on Form 10-Q for the quarters ended March 31, and
June 30, 2007.
4. The description of our Common Stock contained in our Registration
Statement on Form S-18 filed on March 26, 1981, including any amendments or
reports filed for the purpose of updating that description.
5. All documents filed by us pursuant to Section 13(a), 13(c), 14, or 15(d)
of the Securities Exchange Act of 1934, as amended (the "1934 Act") subsequent
to the date of this Prospectus and before the termination of this offering shall
be deemed to be incorporated by reference and a part of this Prospectus from the
date on which such documents are filed.
For purposes of this Prospectus, any statement in a document incorporated
or deemed incorporated by reference is modified or superseded to the extent that
a statement in this Prospectus, or in any subsequently filed document which is
or is deemed to be incorporated by reference, modifies or supersedes it. Any
statement so modified or superseded is not, except as so modified or superseded,
to constitute a part of this Prospectus.
RISK FACTORS
Before you invest in our Common Stock, you should consider carefully the
following risk factors and cautionary statements, as well as other information
set forth in and incorporated by reference into this prospectus. If any of the
following risks actually occur, our business, financial condition or results of
operation may suffer. As a result, the trading price of our Common Stock could
decline, and you could lose a substantial portion of the money you paid to buy
our Common Stock. The risks and uncertainties we describe below are not the only
ones we face. Additional risks and uncertainties that we do not currently know
or that we currently believe to be immaterial may also adversely affect our
business.
1. We are engaged in a very competitive business. We have several national
and regional competitors in the marine market place. The competition is based on
brand recognition, price, service and the ability to deliver products on a
timely basis.
2. There are many entities in the marine and automotive market places, both
national and regional which compete with us. Many of these competitors are more
established and have greater financial resources. We must compete on the basis
of brand recognition, price, service and the ability to deliver products on a
timely basis with larger and financially stronger competitors.
3. We also have competitors in the recreational vehicle appearance and
maintenance market. Our competitors are national and regional and we must
compete in a similar manner as our competition the marine market.
4. Our five largest customers represented approximately 59% and 43%, of
consolidated gross revenues for the years ended December 31, 2006 and 2005,
respectively; and 57% and 26% of consolidated accounts receivable at December
31, 2006 and 2005, respectively. We have had a longstanding relationship with
each of these entities and have always collected open receivable balances.
However, the loss of any of these customers could have an adverse impact on our
operations.
5. Certain aspects of the company business, primarily in the marine
industry are greatly influenced by the economy and the weather. A bad economy
directly impacts our sales to the recreational boating public and cold or other
inclement weather either delays the start or shortens the length of the boating
season and has an adverse impact on our sales.
6. We depend on the delivery of quality products on a timely basis on both
our own manufactured capacity as well as our third party suppliers. If our
manufacturing facilities or any of our suppliers' facilities are unable to
timely meet demand, the company's sales and reputation would be damaged.
7. As manufacturers of products, we are exposed to products liability
claims and lawsuits.
8. We depend upon the continued services of a small number of executives,
and the loss of any of those executives could create a void in management that
we are unable to fill with a person having appropriate expertise and experience
with our business.
4
OUR COMPANY
We were organized on November 13, 1973 under the laws of the state of
Florida. We are principally engaged in the manufacturing, marketing and
distribution of a broad line of appearance and maintenance products for boats,
recreational vehicles, automotive and aircraft under the "Star brite" name
within the United States of America and Canada. In addition, we produce private
label formulations of many of our products for various customers as well as
custom blending and packaging services of these and other products to customer
specifications.
Examples of products which we manufacture and market are:
Marine: The Marine line consists of polishes, cleaners, protectants and
waxes of various formulations. The line also includes various vinyl protectants,
cleaners, teak cleaners, teak oils, bilge cleaners, hull cleaners, silicone
sealants, polyurethane sealants, polysulfide sealants, gasket materials,
lubricants, antifouling additives and anti-freeze coolants. In addition, we
manufacture a line of brushes, poles and tie-downs.
Automotive: We manufacture a line of automotive products under the Star
brite brand name including brake and transmission fluids, hydraulic, gear and
motor oils, and related items. In addition, antifreeze and windshield washes are
produced in varying formulations both under the Star brite brand as well as
private labeled for customers. We have a line of automotive polishes, cleaners
and associated appearance items.
Recreational vehicle: The recreational vehicle products are made up of
cleaners, polishes, detergents, fabric cleaners and protectors, silicone
sealants, waterproofers, gasket materials, degreasers, vinyl cleaners,
protectors and anti-freeze coolants.
Aircraft: Aircraft products consist primarily of polishes and cleaners.
We manufacture the majority of our products but we also contract with
unrelated companies to package other products which are manufactured to the our
specifications, using our provided formulas.
Our marine products and recreational vehicle products are sold through
national mass merchandisers such as Wal-Mart and Home Depot and through
specialized marine retailers such as West Marine and Boater's World. Our
customers also include distributors who in turn sell our products to specialized
retail outlets for a specific market.
SELLING STOCKHOLDERS
This Prospectus relates to shares of Common Stock that are being registered
for reoffers and resale by selling stockholders pursuant to a Rule 10b5-1(c)
Trading Plan who have acquired shares of Common Stock through the exercise of
stock options under the Plans. Some of the selling stockholders may be deemed
"affiliates" of the Company. An "affiliate" is defined under the Securities Act
as "a person that directly or indirectly, through one or more intermediaries,
controls or is controlled by, or is under common control with" Ocean Bio-Chem,
Inc. The selling stockholders may resell any or all of the shares of Common
Stock at any time while this Prospectus is effective.
All selling stockholders have informed us of an intent to sell their
shares. The inclusion of the shares of Common Stock in the table below does not
constitute a commitment to sell any shares.
The information in the table below is based on information available to us
as of October 19, 2007.
Number of Number of
Shares Offered Shares Owned
by the Selling Number of after the Percent of
Name Position Plan Stockholders(1) Shares Owned (2) Offering (3) Shares Owned (4)
Peter G. Dornau President, Chief
Executive Officer 2002 25,000 5,618,368 5,593,368 55.20%
and Director
Gregor M. Dornau Vice President 2002 20,000 361,780 341,780 3.37%
Edward Anchel Director 2002 25,000 316,159 291,159 2.87%
Sonia B. Beard Director 2002 20,000 30,000 10,000 .10%
Jeffrey J. Tieger 2002 25,000 429,664 404,664 3.99%
Jerry Pittman 2002 15,000 70,809 55,809 .55%
Jean Paul Kitzinger 2002 10,000 66,000 56,000 .55%
Daniel Davis 2002 5,000 36,500 31,500 .31%
5
(1) Represents the number of shares purchased under the Plan by such person
and registered for sale.
(2) For each selling stockholder this includes (i) shares of our Common
Stock owned as of October 19, 2007, (ii) shares of our Common Stock underlying
options and warrants which are exercisable within sixty (60) days of October 19,
2007, and (iii) shares of our Common Stock underlying options and warrants
granted by the Company exercisable after sixty (60) days of October 19, 2007.
(3) Assumes the sale of all shares eligible to be sold.
(4) Percentages are after the contemplated sale of all shares eligible to
be sold.
PLAN OF DISTRIBUTION
The selling stockholders may sell registered Shares in any of the following
ways:
-- through dealers;
-- through agents; or
--directly to one or more purchasers.
The distribution of the Shares are being sold Pursuant to a Rule 10b5-1(c)
Trading Plan and may be effected from time to time in one or more transactions
(which may involve crosses or block transactions):
-- on the NASDAQ in transactions pursuant to and in accordance with the
rules of such exchange;
-- in the over-the-counter market; or
-- in transactions other than on such exchange or in the over-the-counter
market, or a combination of such transactions.
Any such transaction may be effected at market prices prevailing at the
time of sale, at prices related to such prevailing market prices, at negotiated
prices or at fixed prices. The selling stockholders may effect such transactions
by selling Shares to or through broker-dealers, and such broker-dealers may
receive compensation in the form of discounts, concessions or commissions from
the selling stockholders and/or commissions from purchasers of Shares for whom
they may act as agent. The selling stockholders and any broker-dealers or agents
that participate in the distribution of Shares by them might be deemed to be
underwriters, and any discounts, commissions or concessions received by any such
broker-dealers or agents might be deemed to be underwriting discounts and
commissions, under the Securities Act. Affiliates of one or more selling
stockholders may act as principal or agent in connection with the offer or sale
of Shares by the selling stockholders.
USE OF PROCEEDS
The Company will not receive any of the proceeds from the reoffer and
resale of the Shares by the selling stockholders.
EXPENSES
All expenses of this offering, including the expenses of the registration
of the Shares of Common Stock offered by the selling stockholders, will be borne
by us. It is estimated that the total amount of such expense will not exceed
$15,000.00.
EXPERTS
The financial statements incorporated in this Prospectus by reference to
the Annual Report on Form 10-K for the year ended December 31, 2006 have been
audited by Berenfeld, Spritzer, Shechter & Sheer, and Levi & Gopman P.A.
(formally known as Levi Cahlin & Co.) for the years ended December 31, 2005 and
2004 and have been so incorporated in reliance on the reports of Berenfeld,
Spritzer, Shechter & Sheer, and Levi Gopman P.A., (formally known as Levi Cahlin
& Co., independent registered accountants, given on the authority of said firms
as experts in auditing and accounting.
CERTAIN FORWARD-LOOKING STATEMENTS
Except for any historical information contained herein, the matters
discussed in this Prospectus contain certain "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of 1995. These
statements relate to analyses and other information, which are based on
forecasts of future results and estimates of amounts not yet determinable. These
statements also relate to our future prospects, future financial performance,
developments and business strategies.
6
In some instances, these forward-looking statements are identified by their
use of terms and phrases such as "anticipate," "believe," "could," "estimate,"
"expect," "intend," "may," "plan," "predict," "project," "will" and similar
terms and phrases, including references to assumptions. Some of the
forward-looking statements appear in the sections entitled "Risk Factors," "Plan
of Distribution and "Selling Shareholders"; and elsewhere included or
incorporated by reference into the Prospectus.
Forward-looking statements are only predications. Although we believe that
our plans, intentions and expectations reflected in or suggested by such
forward-looking statements are reasonable, we cannot assure you that such plans,
intentions or expectations will be achieved. Important factors that could cause
actual results to differ materially from our forward-looking statements include,
among others, the risks outlined in the "Risk Factors" section of this
Prospectus, economic downturns; terrorist acts upon the United States; threat of
or actual war; unfavorable weather conditions; our ability to integrate and
successfully operate future acquisitions; and other future events. All
forward-looking statements attributable to us or any persons acting on our
behalf are expressly qualified in their entirety by these cautionary statements.
If one or more of these risks or uncertainties materialize, or if
underlying assumptions prove incorrect, our actual results may vary materially
from those expected, estimated or projected. Given these uncertainties, users of
the information included in this Prospectus, including investors and prospective
investors, are cautioned not to place undue reliance on such forward-looking
statements. We will not update these forward-looking statements, even if new
information, future events or other circumstances have made them incorrect or
misleading.
INDEMNIFICATION OF OFFICERS, DIRECTORS AND CONTROLLING PERSONS
Pursuant to Section 607.0831 of the Florida Business Corporation Act
("FBCA") the Company's officers and directors are not personally liable to the
Company or any person for action taken by them unless the officer or director
commits certain violations or engages in certain improper conduct set forth in
FBCA Section 607.0850. In addition, FBCA Section 607.0850 permits the Company to
indemnify its officers and directors, and the Company's bylaws provide that the
Company shall indemnify its officers and directors and former officers and
directors to the full extent permitted by law. Insofar as indemnification for
liabilities arising under the Securities Act of 1933 ("the Act") may be
permitted to directors, officers and controlling persons of the small business
issuer pursuant to the foregoing provisions, or otherwise, the small business
issuer has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act
and is, therefore, unenforceable.
INFORMATION REQUIRED IN 10(a) PROSPECTUS
Item 1. Plan Information.*
Item 2. Registrant Information and Employee Plan Annual Information.*
*The information required by Items 1 and 2 of Form S-8 is omitted from this
Registration Statement in accordance with the Note to Part I of Form S-8 and
Rule 428 promulgated under the Securities Act of 1933, as amended (the
"Securities Act").
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents filed by the Registrant with the Securities and
Exchange Commission are incorporated herein by Reference with this Registration
Statement:
1. The Company's Annual Report on Form 10-K for the year ended December 31,
2006.
2. The Company's Proxy Statement for the Annual Meeting of Shareholders
held on August 3, 2007.
3. The Company's Quarterly Report on Forms 10-Q for the quarters ended
March 31, and June 30, 2007.
4. The description of our Common Stock contained in our Registration
Statement on Form S-18 filed on March 26, 1981, including amendments and reports
filed updating that description.
Any statement contained in a document incorporated by reference herein
shall be deemed to be modified or superseded for purposes of this Registration
Statement to the extent that a statement contained herein, or in a subsequently
filed document incorporated by reference herein, modifies or supersedes such
statement. Any such statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute part of this Registration
Statement.
7
Item 4. Description of Securities.
The Company is authorized to issue up to 10,000,000 shares of Common Stock,
par value $.01 per share. The holders of such shares of Common Stock are
entitled to one (1) vote for each share held as of a record date for matters
submitted to a vote of shareholders. There is no cumulative voting for election
of directors. Holders of Common Stock are entitled to receive ratably any
dividends declared by the Board of Directors out of funds legally available
therefore, and, upon a liquidation, dissolution, or winding up of the Company
are entitled to share ratably in all assets remaining after payment of
liabilities and payment of accrued dividends, if any. Holders of Common Stock
have no pre-emptive rights and have no rights to convert their Common Stock to
any other securities. The outstanding Common Stock is, and the Common Stock to
be outstanding upon completion of this offering will be, validly issued, fully
paid and non-assessable.
Item 5. Interests of Named Experts and Counsel.
Validity of the Common Stock offered hereby and certain other legal matters
will be passed upon for the Company by Berger Singerman, Attorneys at Law, 350
East Las Olas Boulevard, Suite 1000, Fort Lauderdale, Florida 33301. Mr.
Schneider, a director of the Company, and the holder of options to purchase
40,000 shares of the Company's Stock, is a shareholder of Berger Singerman.
The Financial Statements of the Company as of December 31, 2006 and 2005
and for the years ended December 31, 2006, 2005 and 2004 which have been
incorporated herein by reference to the Form 10-K of the Company were audited
by, and filed in reliance upon the reports of Berenfeld, Spritzer, Shechter &
Sheer, 401 East Las Olas Boulevard, Suite 1090, Fort Lauderdale, Florida 33301,
and Levi Gopman & P.A., (formally known as Levi Cahlin & Co.), 20590 West Dixie
Highway, North Miami Beach, Florida 33180.
Item 6. Indemnification of Directors and Officers.
FLORIDA BUSINESS CORPORATION ACT. Section 607.0831 of the Florida Business
Corporation Act (the "Florida Act") provides that a director is not personally
liable for monetary damages to the corporation or any person for any statement,
vote, decision or failure to act regarding corporate management or policy, by a
director, unless: (a) the director breached or failed to perform his duties as a
director; and (b) the director's breach of, or failure to perform, those duties
constitutes: (i) a violation of criminal law unless the director had reasonable
cause to believe his conduct was lawful or had no reasonable cause to believe
his conduct was unlawful; (ii) a transaction from which the director derived an
improper personal benefit, either directly or indirectly; (iii) a circumstance
under which the director is liable for an improper distribution; (iv) in a
proceeding by or in the right of the corporation to procure a judgment in its
favor or by or in the right of a shareholder, conscious disregard for the best
interests of the corporation, or willful misconduct; or (v) in a proceeding by
or in the right of someone other than the corporation or a shareholder,
recklessness or an act or omission which was committed in bad faith or with
malicious purpose or in a manner exhibiting wanton and willful disregard of
human rights, safety or property.
Section 607.0850 of the Florida Act provides that a corporation shall have
the power to indemnify any person who was or is a party to any proceeding (other
than an action by, or in the right of, the corporation), by reason of the fact
that he is or was a director, officer or employee or agent of the corporation
against liability incurred in connection with such proceeding if he acted in
good faith and in a manner he reasonably believed to be in, or not opposed to,
the best interests of the corporation and, with respect to any criminal action
or proceeding, had no reasonable cause to believe his conduct was unlawful.
Section 607.0850 also provides that a corporation shall have the power to
indemnify any person who was or is a party to any proceeding by, or in the right
of, the corporation to procure a judgment in its favor by reason of the fact
that he is or was a director, officer, employee or agent of the corporation,
against expenses and amounts paid in settlement not exceeding, in the judgment
of the board of directors, the estimated expense of litigating the proceeding to
conclusion, actually and reasonably incurred in connection with the defense or
settlement of such proceeding, including any appeal thereof.
8
Section 607.0850 further provides that such indemnification may be
authorized if such person acted in good faith and in a manner he reasonably
believed to be in, or not opposed to, the best interests of the corporation,
except that no indemnification shall be made under this provision in respect of
any claim, issue, or matter as to which such person shall have been adjudged to
be liable unless, and only to the extent that, the court in which such
proceeding was brought, or any other court of competent jurisdiction, shall
determine upon application that, despite the adjudication of liability, but in
view of all circumstances of the case, such person is fairly and reasonably
entitled to indemnity for such expenses which such court shall deem proper.
Section 607.0850 further provides that to the extent that a director, officer,
employee or agent has been successful on the merits or otherwise in defense of
any of the foregoing proceedings, or in defense of any claim, issue or matter
therein, he shall be indemnified against expenses actually and reasonably
incurred by him in connection therewith. Under Section 607.0850, any
indemnification under the foregoing provisions, unless pursuant to a
determination by a court, shall be made by the corporation only as authorized in
the specific case upon a determination that the indemnification of the director,
officer, employee or agent is proper under the circumstances because he has met
the applicable standard of conduct. In addition to the foregoing, Section
607.0850 permits a corporation further to indemnify such persons by other means
unless a judgment or other final adjudication establishes that such person's
actions or omissions which were material to the cause of action constitute (1) a
crime (unless such person had reasonable cause to believe his conduct was lawful
or had no reasonable cause to believe it unlawful), (2) a transaction from which
he derived an improper personal benefit, (3) a transaction in violation of
Florida Statutes 607.0834 (unlawful distributions to shareholders), or (4)
willful misconduct or conscious disregard for the best interests of the
corporation in a proceeding by or in the right of the corporation to procure a
judgment in its favor or in a proceeding by or in the right of a shareholder.
Notwithstanding the failure of a corporation to provide indemnification, and
despite any contrary determination by the corporation in a specific case, a
director, officer, employee or agent of the corporation who is or was a party to
a proceeding may apply for indemnification to the appropriate court and such
court may order indemnification if it determines that such person is entitled to
indemnification under the applicable standard.
Section 607.0850 also provides that a corporation shall have the power to
purchase and maintain insurance on behalf of any person who is or was a
director, officer, employee or agent of the corporation against any liability
asserted against him and incurred by him in any such capacity or arising out of
his status as such, whether or not the corporation would have the power to
indemnify him against such liability under the provisions of Section 607.0850.
BY-LAWS. The Registrant's by-laws provide that it shall indemnify its
officers and directors and former officers and directors to the full extent
permitted by law.
DIRECTOR AND OFFICER LIABILITY INSURANCE. The Registrant's directors and
officers are covered by insurance policies indemnifying them against certain
liabilities, including liabilities under the federal securities laws (other than
liability under Section 16(b) of the Exchange Act), which might be incurred by
them in such capacities.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
4(a)(1) Ocean Bio-Chem, Inc. 2002 Incentive Stock Option Plan
4(a)(2) Ocean Bio-Chem, Inc. 2002 Non-Qualified Stock Option Plan
4(b) Rule 10b5-1 Sales Trading Plan
23(a) Consent of Berenfeld, Spritzer, Shechter & Sheer
23(b) Consent of Levi & Gopman, P.A. (formerly known as Levi Cahlin & Co.
9
Item 9. Undertakings.
The undersigned Registrant hereby undertakes:
1. To file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement:
(i) To include any Prospectus required by Section 10(a)(3) of the
Securities Act of 1933, as amended (the "Securities Act").
(ii) To reflect in the Prospectus any facts or events arising after the
effective date of the Registration Statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in this Registration Statement.
(iii) To include any additional or changed material information with
respect to the plan of distribution not previously disclosed in the Registration
Statement;
provided, however, that paragraphs (i) and (ii) do not apply if the
information required to be included in a post-effective amendment is contained
in periodic reports filed with or furnished to the Commission by the Registrant
pursuant to Section 13 or Section 15(d) of the Exchange Act that are
incorporated by reference in this Registration Statement.
2. That, for the purpose of determining any liability under the Securities
Act, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering
thereof.
3. To remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the termination of
this offering.
4. The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the
Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the
Exchange Act (and, where applicable, each filing of an employee benefit plan's
annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in the Registration Statement shall be deemed to be a
new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
5. Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the foregoing provisions, or otherwise, the Registrant
has been advised that in the opinion of the Commission such indemnification is
against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Registrant of expenses incurred or
paid by a director, officer or controlling person of the Registrant in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
10
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Fort Lauderdale, State of Florida, on this 23rd day
of October, 2007.
OCEAN BIO-CHEM, INC.
President and
Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on this 23rd day of October, 2007.
Signature Title
(a) Chief Executive Officer
/s/ Peter G. Dornau President, Chairman of the Board, Chief
Peter G. Dornau Executive Officer and Director
(b) Chief Financial Officer
/s/ Jeffrey S. Barocas Vice President-Finance, Chief
Jeffrey Barocas Financial Officer and Director
(c) Directors
/s/ Peter G. Dornau Director
Peter G. Dornau
/s/ Edward Anchel Director
Edward Anchel
/s/ Gregor M. Dornau Director
Gregor M. Dornau
/s/ William W. Dudman
William W. Dudman Director
/s/ Jeffrey S. Barocas Director
Jeffrey S. Barocas
/s/ Laz L. Schneider Director
Laz L. Schneider
/s/ James Kolisch Director
James Kolisch
/s/ John B. Turner Director
John B. Turner
/s/ Sonia B. Beard Director
Sonia B. Beard
Pursuant to the requirements of the Securities Act of 1933, the Trustees
(or other persons who administer the employee benefits plan) have duly caused
this Registration Statement to be signed on its behalf by the undersigned
thereunto duly authorized in the City of Fort Lauderdale, State of Florida on
this 23rd day of October, 2007.
Ocean Bio-Chem, Inc. 2002 Incentive Stock
Option Plan and 2002 Non-Qualified Stock
Option Plan
By:/s/ Peter G. Dornau
Peter G. Dornau, Trustee
By:/s/ Jeffrey S. Barocas
Jeffrey S. Barocas, Trustee
11
POWER OF ATTORNEY
For Registration Statement of Ocean Bio-Chem, Inc.
KNOW BY THESE PRESENTS, That each of the undersigned directors and officers
of Ocean Bio-Chem, Inc., a Florida corporation (the "Company"), which proposes
to file with the Securities and Exchange Commission, Washington, DC ("SEC")
under the provisions of the Securities Act of 1933, as amended (the "Act"), a
new S-8 Registration Statement and one or more post-effective amendments
("Registration Documents") to register under said Act an additional 145,000
shares of the Common Stock of the Company to be used in connection with the
Company's Plan, hereby constitutes and appoints Jeffrey S. Barocas his true and
lawful attorney-in-fact and agent, with full power to act as his true and lawful
attorney-in-fact and agent, for him and in his name, place and stead, in any and
all capacities, to sign the Registration Documents and to file the same with all
exhibits thereto and any and all other documents in connection therewith, with
the SEC, hereby granting unto said attorney-in-fact and agent full power and
authority to do and perform any and all acts and things requisite and necessary
to be done in and about the premises as fully and to all intents and purposes as
he might or could do in person, hereby ratifying and confirming all that said
attorney-in-fact and agent may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned have hereunto set their hand this 23rd
day of October, 2007.
Signatures Title
/s/ Peter G. Dornau President, Chief Executive
Peter G. Dornau Officer and Director
/s/ Jeffrey S. Barocas Vice President-Finance,
Jeffrey S. Barocas Chief Financial Officer
and Director
/s/ Gregor M. Dornau Vice President-Sales and
Gregor M. Dornau Marketing and Director
/s/ William W. Dudman Vice President-Operations
William W. Dudman and Director
/s/ Edward Anchel Director
Edward Anchel
/s/ Laz L. Schneider Director
Laz L.Schneider
/s/ James Kolisch Director
James Kolisch
/s/ John B. Turner Director
John B. Turner
/s/ Sonia B. Beard Director
Sonia B. Beard
12
Exhibit Index
Exhibit Number:
4(a)(1) Ocean Bio-Chem, Inc. 2002 Incentive Stock Option Plan
4(a)(2) Ocean Bio-Chem, Inc. 2002 Non-Qualified Stock Option Plan
4(b) Rule 10b5-1 Sales Traing Plan
23(a) Consent of Berenfeld, Spritzer, Shechter & Sheer
23(b) Consent of Levi & Gopman , P.A.(formerly known as Levi Cahlin & Co.
Exhibit 4(a)(1)
OCEAN BIO-CHEM, INC.
2002 INCENTIVE STOCK OPTION PLAN
EFFECTIVE OCTOBER 22, 2002
1. PURPOSE
1.1 GENERAL. Ocean Bio-Chem, Inc., a Florida corporation (the "Company"),
established this Incentive Stock Option Plan (the "Plan") to further the
Company's growth and development by providing to officers and other key
employees who are in a position to contribute materially to the prosperity of
the Company, through ownership of stock of the Company, an incentive to increase
their interest in the Company's welfare, to continue their services and to
afford a means through which the Company can attract to its service other
employees of outstanding ability.
1.2 COMPANY. For purposes of the Plan, the Company is deemed to include all
wholly owned subsidiaries of the Company.
1.3 TAX TREATMENT. The Plan is adopted with the intent that it be, and
continue to be, an "incentive stock option plan" entitling the holders of
options to the special tax treatment provided by Section 422 of the Internal
Revenue Code of 1986 (the "Code").
2. ADMINISTRATION
2.1 STOCK OPTION COMMITTEE. The Plan shall be administered by the Ocean
Bio-Chem, Inc., Stock Option Plan Committee (the "Committee") which shall be
composed of at least two Non-Employee directors of the Company. The Committee,
to be appointed by the Board of Directors, shall have full and complete power
and authority to do all things necessary and proper for the administration of
the Plan, including the power to interpret and construe its terms and provisions
and to determine, consistent with the terms of the Plan, the individuals
selected to receive options, the times when they shall receive them, the number
of shares to be subject to each option, and the option price.
2.2 RULES AND REGULATIONS. The Committee, as it may deem advisable, may
issue rules and regulations for the administration of the Plan. When so directed
by the Committee, appropriate officers of the Company shall execute and deliver
on behalf of the Company such options, agreements and other instruments as the
Committee may determine necessary to the implementation of the Plan. The
Committee may adopt and/or construe an appropriate form for any such options or
agreements and instruments, which forms shall contain such provisions or
conditions as the Committee deems necessary or advisable in carrying out the
purposes of the Plan, provided, however, that no such provision or condition
shall be inconsistent with the Plan.
2.3 DEFECTS OR OMISSIONS. The Committee may correct any defect or supply
any omission or reconcile any inconsistency in the Plan or in any option or
agreement in the manner and to the extent it shall deem expedient to carry it
into effect, and to meet the requirements of Section 422 of the Code, and shall
be the sole and final judge of such expediency. The Committee's determination
shall be conclusive.
3. STOCK SUBJECT TO THE PLAN
3.1 NUMBER OF SHARES. Shares of the Company's Common Stock, par value $.01
per share ("Common Stock") shall be subject to the Plan. The total number of
shares of Common Stock which may be sold pursuant to options granted under the
Plan ("Option" or "Options") shall not exceed 400,000 shares, adjusted as
provided in Section 3.2. The shares of Common Stock sold under the Plan may be
either authorized and unissued shares or issued shares reacquired by the
Company. Unless and until the Board of Directors shall determine to purchase
shares in the market for the purpose of the Plan or to use treasury shares, the
shares sold under the Plan shall be authorized and unissued shares reserved for
that purpose. In the event that any Options granted under the Plan shall
terminate or expire for any reason without having been exercised in full, the
shares of Common Stock not purchased under those Options shall be available
again for the purpose of the Plan.
3.2 ADJUSTMENTS. Notwithstanding any other provision of the Plan, in the
event of any change in any shares of the outstanding Common Stock of the Company
by reason of a stock dividend, recapitalization, merger, consolidation,
split-up, stock split, reverse stock split, combination or exchange of shares,
or action of like nature, the aggregate number and class of shares as to which
Options may be granted to any individual, the number and class of shares subject
to each outstanding Option and the Option prices shall be appropriately adjusted
in proportion to such increases or decreases by the Committee, whose
determination shall be conclusive.
3.3 REVERSION OF SHARES TO THE SHARE RESERVE. If any Stock Award shall for
any reason expire or otherwise terminate, in whole or in part, without having
been exercised in full, the shares of Common Stock not acquired under such Stock
Award shall revert to and again become available for issuance under the Plan.
3.4 SOURCE OF SHARES. The shares of Common Stock subject to the Plan may be
unissued shares or reacquired shares, bought on the market or otherwise.
4. ELIGIBILITY AND PARTICIPATION
4.1 INCENTIVE STOCK OPTION $100,000 LIMITATION. To the extent that the
aggregate Fair Market Value (determined at the time of grant) of Common Stock
with respect to which Incentive Stock Options are exercisable for the first time
by any Optionholder during any calendar year (under all plans of the Company and
its Affiliates) exceeds one hundred thousand dollars ($100,000), the Options or
portions thereof which exceed such limit (according to the order in which they
were granted) shall be treated as Nonstatutory Stock Options.
4.2 OFFICERS AND CERTAIN EMPLOYEES. Options may be granted only to
full-time salaried officers and key employees of the Company or any of its
subsidiaries. Directors of the Company who are not also full-time salaried
officers or employees of the Company will not be eligible to receive Options.
4.2 TEN PERCENT SHAREHOLDER LIMITATION. If an Option is to be granted to an
individual who, at the time the Option is granted, owns Common Stock possessing
more than 10 percent (10%) of the total combined voting power of all classes of
stock of the Company or of its parent or subsidiary (as determined under Section
425(d) of the Code), the purchase price of the Common Stock under each Option
("Option Price") set out in the applicable portion of Article 5 hereof shall
read "but shall be at least 110 percent of its Fair Market Value" and the period
of exercise set out in the applicable portion of Article 6 hereof shall read
"and ending not more than five (5) years after the date on which the option is
granted".
5. PRICE
5.1 DETERMINATION. The Option Price shall be determined by the Committee,
but shall not be less than 100 percent of its fair market value (as determined
by Section 422 of the Code) ("Fair Market Value") at the time of granting of the
Option, as determined in good faith by the Committee.
5.2 PAYMENT. Upon exercise of the Option, the Option Price shall be paid in
full with cash or with stock of the Company or with demand promissory notes
bearing the rate of interest required by the Code, as amended from time to time,
at the option of the Employee.
5.3 USE OF PROCEEDS. The proceeds from the issuance of Common Stock subject
to Options are to be added to the funds of the Company available for its general
corporate purposes.
6. EXERCISE OF OPTION
6.1 PERIOD OF EXERCISE. Each Option granted under the Plan shall be
exercisable only during such period as the Committee may determine, beginning
not less than one (1) year and ending not more than ten (10) years after the
date on which the Option is granted ("Expiration Date"), except as such period
may be modified under the provisions or Sections 8.1 and 9.1 hereof. Within such
limits each Option shall provide, as determined by the Committee, the time or
times at which and the number of shares for which it may be exercised. Unless
otherwise provided in the Committee's action, each Option shall be exercisable
in whole at any time, or in part from time to time, during the term of the
Option. The holder of an Option shall have no rights as a shareholder with
respect to shares subject to the Option until such shares shall have been issued
to him upon exercise of the Option. An Option may be exercised during the
lifetime of the holder thereof only by such holder, and, after the holder's
death, as provided in Sections 9.1 and 9.2 hereof.
6.2 CHANGE OF CONTROL. Provided however, in the event of a change in
control of Company, each Option granted under this Plan shall be fully
exercisable.
6.3 SALE. An individual who has acquired Common Stock upon exercise of an
Option may not sell, transfer or otherwise dispose of the Common Stock so
acquired within two years from the date of the granting of the Option nor within
one year after the transfer of the shares to the individual.
6.4 VESTING GENERALLY. The total number of shares of Common Stock subject
to an Option may, but need not, vest and therefore become exercisable in
periodic installments that may, but need not, be equal. The Option may be
subject to such other terms and conditions on the time or times when it may be
exercised (which may be based on performance or other criteria) as the Board may
deem appropriate. The vesting provisions of individual Options may vary. The
provisions of this Section 6(g) are subject to any Option provisions governing
the minimum number of shares of Common Stock as to which an Option may be
exercised.
7. NON-TRANSFERABILITY OF OPTIONS
7.1 GENERAL. No Option granted under the Plan shall be transferable
otherwise than by will or the laws of descent and distribution.
8. TERMINATION OF EMPLOYMENT
8.1 GENERAL. If employment of the holder of an Option is terminated for any
reason, other than by death or disability, the holder's Option may be exercised
only within three months from the date of such termination of employment, but in
no event after the Expiration Date of the Option; provided, however, that if the
holder is dismissed for cause, as to which the Committee shall be sole and
exclusive judge, the Option shall expire immediately.
9.1 DEATH WHILE EMPLOYED. If the holder of an Option dies while employed by
the Company, the Option may be exercised by the personal representative of the
Option holder, for a period of six (6) months from the date of death, but in no
event after the Expiration Date of the Option.
9.2 DEATH AFTER TERMINATION. If the holder of an Option dies within three
months after termination of employment other than for cause, the Option may be
exercised by the personal representative of the Option holder for a period of
six (6) months from the date the Option holder's employment was terminated, but
in no event after the Expiration Date of the Option.
9.3 DISABILITY. If the holder of an Option becomes disabled within the
meaning of Section 22(e)(3) of the Code, the Option may be exercised by the
Option holder within one year after his becoming disabled, but in no event after
the Expiration Date of the Option.
10. AMENDMENT AND TERMINATION
10.1 TERM. Unless the Plan has been terminated as hereinafter provided, the
Plan shall terminate on October 21, 2012, and no Option under it shall be
granted thereafter. The Board of Directors of the Company at any time prior to
that date may terminate the Plan.
10.2 AMENDMENT. The Board of Directors may also amend the Plan by making
such changes and additions to it as the Board shall deem advisable; provided,
however, that except as provided in Section 3.2 hereof, the Board of Directors
may not, without further approval by the Shareholders of the Company, increase
the maximum number of shares as to which Options may be granted or exercised;
and provided further, that any such change or addition does not affect the
Plan's status under Section 422 of the Code. No termination or amendment of the
Plan may, without the consent of the holder of an Option then existing,
terminate his Option or materially and adversely affect his rights under the
Option.
11. EFFECTIVE DATE
11.1 SHAREHOLDER APPROVAL. The Plan shall become effective upon adaption by
the Board of Directors of the Company, provided that it shall be approved by the
vote of the holders of a majority of the shares of Common Stock of the Company
outstanding and entitled to vote at a meeting of shareholders held within twelve
(12) months after the Plan is adopted by the Board of Directors.
12. TIME OF GRANTING OF OPTIONS
12.1 FORMAL GRANTING. Nothing contained in the Plan or in any resolution
adopted or to be adopted by the Board of Directors or the shareholders of the
Company shall constitute the granting of an Option hereunder. The granting of an
Option pursuant to the Plan and the acquisition of any rights as an Option
holder shall take place only when the Committee authorizes the issuance of an
Option, and a formal written and executed Option agreement is executed by the
holder of the Option.
12.2 TEN YEAR LIMIT. Subject to the provisions of Article 10, Options may
be granted under the Plan within ten (10) years from the date the Plan is
adopted by the Board of Directors of the Company or the date the Plan is
approved by the Shareholders, whichever is earlier.
13. MISCELLANEOUS PROVISIONS
13.1 OPTION DATE. An Option shall have been deemed to have been granted on
the date fixed in the resolution of the Committee authorizing the granting of
such Option, provided such date shall not be prior to the date of the adoption
of such resolution. If no date is fixed by such resolution, the Option shall be
deemed to have been granted on the date of adoption of the resolution, provided
that the agreement relating to the Option shall be executed and delivered within
thirty (30) days therefrom; otherwise the Option shall be deemed to have been
granted on the date of delivery of such agreement to the optionee.
13.2 INDEMNIFICATION OF COMMITTEE. Without limiting any other rights of
indemnification, the members of the Committee shall be indemnified by the
Company against the reasonable expenses (including attorney's fees, judgments,
fines, and amounts paid in settlement) actually incurred as a result of any
action, suit or proceeding, or any appeal therein ("Claim"), to which they or
any of them may be a party by reason of any action taken or failure to act under
or in connection with the Plan, and against all amounts paid by them in
settlement of such Claim, to the full extent permissible under Florida Law;
provided that within sixty (60) days after institution of any such Claim, the
Committee member involved offers the Company in writing the opportunity, at its
Own expense, to handle and defend the same.
13.3 JURISDICTION AND VENUE. This Agreement shall be governed by the laws
of the state of Florida and any litigation with respect to this Agreement shall
be in the state or Federal courts situated in Broward County, Florida
Exhibit 4(a)(2)
2002 NON-QUALIFIED STOCK OPTION PLAN
ADOPTED BY THE BOARD OF DIRECTORS
ON OCTOBER 22, 2002,
EFFECTIVE AS OF OCTOBER 22, 2002
1. PURPOSE.
(a) The purpose of the Ocean Bio-Chem, Inc. 2002 Non-Qualified Stock Option
Plan (the "2002 Non-Qualified Plan") is to strengthen Ocean Bio-Chem, Inc. (the
"Company") and its subsidiary corporation, within the meaning of Section 425 of
the Internal Revenue Code of 1986, as amended (the "Code"), by providing
directors who are not full-time salaried employees (the "Non-Employee
Directors") and consultants, such as, for example, but without limitation, legal
or financial service providers or software, hardware, or other product designers
("Consultants") added incentives for high levels of performance and to encourage
stock ownership in the Company. The 2002 Non-Qualified Plan seeks to accomplish
these goals by providing a means whereby such Non-Employee Directors and
Consultants of the Company and its subsidiaries may be given an opportunity to
purchase (by way of an option) common stock of the Company.
(b) The Company, by means of the 2002 Non-Qualified Plan, seeks to secure
and retain the services of such Non-Employee Directors and Consultants of the
Company or its subsidiaries and to provide incentives for such persons to exert
maximum efforts for the success of the Company and its subsidiaries.
(c) The Company intends that the options issued under the 2002
Non-Qualified Plan shall be options which do not qualify as incentive stock
options ("non-qualified stock options").
2. ADMINISTRATION.
(a) The 2002 Non-Qualified Plan has been adopted and shall be administered
by a compensation committee ("Committee"), composed of not fewer than two (2)
members of the Board of Directors (the "Board"). All members of the Committee
must be "outside directors" within the meaning of Section 162(m) of the Code. It
is recommended, and the Board of Directors shall endeavor, to select at least
three (3) members of the Board who qualify as "outside directors") to serve on
the Committee. Members of the Committee shall serve at the pleasure of the Board
and the Board may from time to time remove members from, or add members to, the
Committee. All of the members of the Committee also shall be "Non Employee
Directors" as provided in Rule 16b-3(i) promulgated pursuant to the Securities
Exchange Act of 1934, as amended ("1934 Act").
(b) The Committee shall have the power, in connection with the
administration of the 2002 Non-Qualified Plan, subject to and within the
limitations of the express provisions of the 2002 Non-Qualified Plan:
(i) To determine from time to time which of the persons eligible under the
2002 Non-Qualified Plan shall be granted an option; when and how the option
shall be granted; the provisions of each option granted (which need not be
identical), including, without limitation, the time or times during the term of
each option within which all or portions of such option may be exercised; and
the number of shares for which an option shall be granted to each such person;
(ii) To determine any conditions or restrictions imposed on stock acquired
pursuant to the exercise of an option (including, but not limited to, repurchase
rights, forfeiture restrictions and restrictions on transferability);
(iii) To construe and interpret the 2002 Non-Qualified Plan and the options
granted under it, to construe and interpret any conditions or restrictions
imposed on stock acquired pursuant to the exercise of an option, to define the
terms used herein, and to establish, amend and revoke rules and regulations for
its administration. The Committee, in the exercise of this power, may correct
any defect, omission or inconsistency in the 2002 Non-Qualified Plan or in any
option agreement in a manner and to the extent it shall deem necessary or
expedient to make the 2002 Non-Qualified Plan fully effective;
(iv) To cancel, at any time and from time to time, with the consent of the
affected optionee or optionees, any or all outstanding options granted under the
2002 Non-Qualified Plan and the grant and substitution therefore of new options
under the 2002 Non-Qualified Plan (subject to limitations hereof) covering the
same or different number of shares of stock at an option price per share in all
events not less than the fair market value on the new grant date; and
(v) Generally, to exercise such powers and to perform such acts as it deems
necessary or expedient to promote the best interests of the Company.
(c) The Committee shall comply with the provisions of Rule 16b-3,
promulgated pursuant to the 1934 Act as in effect from time to time, to the
extent applicable to the 2002 Non-Qualified Plan.
(d) Any action of the Committee with respect to administration of the 2002
Non-Qualified Plan shall be taken pursuant to a majority vote or to the
unanimous written consent of its members. In the event that the Committee is
composed of two members, and one member abstains from a vote on a matter, issue
or item for decision, the remaining member may vote and his or her vote shall be
considered a majority vote of the Committee. A vote of the Committee shall be
reported to the full Board of Directors, which may elect to accept such vote or
reconsider the matter and cast a contrary or differing vote, which shall
control. Any member of the Committee who is eligible for an award under this
Plan shall abstain from consideration of such award by the Committee.
(e) The determinations of the Committee on matters referred to in this
paragraph 2 shall be final and conclusive.
3. SHARES SUBJECT TO THE 2002 NON-QUALIFIED PLAN.
Subject to the provisions of paragraph 9 relating to adjustments upon
changes in stock, the stock that may be offered pursuant to options granted
under the 2002 Non-Qualified Plan shall not exceed the aggregate of 200,000
shares of the Company's common stock. If any option granted under the 2002
Non-Qualified Plan shall for any reason expire, be canceled or otherwise
terminate without having been exercised in full, the stock not purchased under
such option shall again become available for the 2002 Non-Qualified Plan.
4. ELIGIBILITY.
(a) Non-Employee Directors and Consultants of the Company or its
subsidiaries shall be eligible to receive non-qualified stock options.
(b) Notwithstanding anything to the contrary contained in this Plan, no
person may be granted an option under this Plan if such person at the time of
grant holds options to purchase more than 10% of the outstanding shares of
common stock of the Company. In addition, no person may be granted (in any
calendar year) options to purchase more than 100,000 shares of common stock,
subject to adjustment pursuant to paragraph 9.
5. OPTION PROVISIONS.
Each option shall be in such form and shall contain such terms and
conditions as the Committee shall deem appropriate. The provisions of separate
options need not be identical, but each option shall include (through
incorporation of provisions hereof by reference in the option or otherwise) the
substance of each of the following provisions:
(a) Each option granted and all rights or obligations thereunder by its
terms shall expire on such date as the Committee may determine as set forth in
such stock option agreement, but not later than ten (10) years from the date the
option was granted and shall be subject to earlier termination as provided
elsewhere in the 2002 Non-Qualified Plan. For purposes of the 2002 Non-Qualified
Plan, the date of grant of an option shall be the date on which the Committee
takes final action approving the award of the option, notwithstanding the date
the optionee accepts the option, the date of execution of the option agreement,
or any other date with respect to such option.
(b) The exercise price of each option shall be determined by the Committee
and shall be not less than one hundred percent (100%) of the "fair market value"
of the stock subject to the option on the date the option is granted, as such
term in quotations is defined below; provided, however, that the purchase price
of common stock subject to an incentive stock option may not be less than one
hundred ten percent (110%) of such fair market value where the optionee owns (or
is deemed to own pursuant to Section 424(d) of the Code) stock possessing more
than ten percent (10%) of the total combined voting power of all classes of
stock of the Company. The fair market value of such stock shall be determined by
the Committee in accordance with any reasonable valuation method.
(c) The purchase price of stock acquired pursuant to an option shall be
paid at the time the option is exercised (i) in cash, check payable to the order
of the Company, or (ii) shares of common stock of the Company with a fair market
value equal to the option price for the shares being purchased; or (iii) having
shares withheld from the total number of shares of Common Stock to be delivered
upon exercise; or (iv) delivering a properly executed notice, together with
irrevocable instructions to a broker, to promptly deliver to the Company the
amount of sale or loan proceeds to pay the exercise price. If a person other
than the optionee exercises an option, such person must furnish the Company
appropriate documentation evidencing that such person or persons have the full
legal right and power to exercise the option on behalf of and for the optionee.
(d) An option by its terms may only be transferred by will or by the laws
of descent and distribution upon the death of the optionee or by a qualified
domestic relations order, as such term is defined in the Internal Revenue Code
of 1986, as amended, and shall not be transferable during the optionee's
lifetime (unless by a qualified domestic relations order), and shall be
exercisable during the lifetime of the person to whom the option is granted only
by such person (unless by a qualified domestic relations order).
(e) Subject to subparagraph 5(f) and except as provided in paragraph 10,
each option shall be exercisable in such installments, which need not be equal,
and upon such contingencies as the Committee shall determine. In addition, the
Committee shall have the power to accelerate the time (other than, except as
provided in paragraph 10, the expiration date) during which an option may be
exercised, notwithstanding the provisions in the option stating the time during
which it may be exercised.
(f) From time to time during each of such installment periods, the option
may be exercised with respect to some or all of the shares allotted to that
period, and/or with respect to some or all of the shares allotted to any prior
period as to which the option was not fully exercised. During the remainder of
the term of the option (if its term extends beyond the end of the installment
periods), the option may be exercised from time to time with respect to any
shares then remaining subject to the option. The provisions of this subparagraph
5(f) are subject to any option provisions governing the minimum number of shares
as to which an option may be exercised.
(g) The Company may require any optionee, or any person to whom an option
is transferred under subparagraph 5(d), as a condition of exercising any such
option, to give written assurances satisfactory to the Company stating that such
person is acquiring the stock subject to the option for such person's own
account and not with any present intention of selling or otherwise distributing
the stock. The requirement of providing written assurances, and any assurances
given pursuant to the requirement, shall be inoperative if (i) the shares to be
issued upon the exercise of the option have been registered under a then
currently effective registration statement under the Securities Act of 1933, as
amended (the "Securities Act"), or (ii) a determination is made by counsel for
the Company that such written assurances are not required in the circumstances
under the then applicable federal or state securities laws.
(i) The stock option agreement may, but need not, provide that such option
may be exercised at any specified time up to one (1) year following the death of
the optioneee by the person or persons to whom the optionee's rights under such
option pass by will or by the laws of descent and distribution, but only to the
extent that the optionee was entitled to exercise said option immediately prior
to death.
(ii) The options may be canceled for "cause", whereupon the option
terminates immediately as to all unexercised options. Cause shall include
termination for malfeasance or gross misfeasance in the performance of duties,
or conviction of illegal activity in connection therewith, conviction for a
felony, or any significant conduct detrimental to the interests of the Company
or any of its subsidiaries, and the determination of the Committee with respect
thereto shall be final and conclusive.
(h) Options may be exercised by ten (10) days' written notice delivered to
the Company stating the number of shares with respect to which the option is
being exercised, together with payment for such shares. Not less than one
hundred (100) shares may be purchased at any one time unless the number
purchased is the total number of shares which may be purchased under the option.
(i) Any option granted hereunder shall provide as determined by the
Committee for appropriate arrangements for the satisfaction by the Company or
its subsidiaries and the optionee of all federal, state, local or other income,
excise or employment taxes or tax withholding requirements applicable to the
exercise of the option or the later disposition of the shares of stock thereby
acquired. Such arrangements shall include, without limitation, the right of the
Company or any subsidiary thereof to deduct or withhold, if permitted by law,
shares of stock from any transfer or payment to an optionee or, if permitted by
law, to receive transfers of shares of stock or other property from the
optionee, in such amount or amounts deemed required or appropriate by the
Committee in its discretion. Any shares of stock issued pursuant to the exercise
of any option and transferred by the optionee to the Company for purposes of
satisfying any withholding obligations shall not again be available for purposes
of the 2002 Non-Qualified Plan.
6. COVENANTS OF THE COMPANY.
(a) During the terms of the options granted under the 2002 Non-Qualified
Plan, the Company shall keep available at all times the number of shares of
stock required to satisfy such options.
(b) The Company shall seek to obtain from each regulatory commission or
agency having jurisdiction over the 2002 Non-Qualified Plan or the Company such
authority as may be required to issue and sell shares of stock upon exercise of
the options granted under the 2002 Non-Qualified Plan; provided, however, that
this undertaking shall not require the Company to register under the Securities
Act either the 2002 Non-Qualified Plan, any option granted under the 2002
Non-Qualified Plan, or any stock issued or issuable pursuant to any such option
or grant. If the Company is unable to obtain from any such regulatory commission
or agency the authority which counsel for the Company deems necessary for the
lawful issuance and sale of stock under the 2002 Non-Qualified Plan, the Company
shall be relieved from any liability for failure to issue and sell stock upon
grant or upon exercise of such options unless and until such authority is
obtained.
(c) The Company shall indemnify and hold harmless the members of the
Committee in any action brought against any member in connection with the
administration of the 2002 Non-Qualified Plan to the maximum extent permitted by
then applicable law.
7. USE OF PROCEEDS FROM STOCK.
Proceeds from the sale of stock pursuant to options granted under the 2002
Non-Qualified Plan shall constitute general funds of the Company.
8. MISCELLANEOUS.
(a) Neither an optionee nor any person to whom an option is transferred
under subparagraph 5(d) shall be deemed to be the holder of, or to have any of
the rights of a holder with respect to, any shares subject to such option unless
and until such person has satisfied all requirements for exercise of the option
pursuant to its terms.
(b) Nothing contained in the 2002 Non-Qualified Plan, or in any option
granted pursuant to the 2002 Non-Qualified Plan, shall obligate the Company or
any of its subsidiaries to employ any employee for any period or interfere in
any way with the right of the Company or any of its subsidiaries to reduce the
compensation of any employee.
9. ADJUSTMENTS UPON CHANGES IN STOCK.
If the outstanding shares of the stock of the Company are increased,
decreased, or changed into, or exchanged for a different number or kind of
shares or securities of the Company, without receipt of consideration by the
Company, through reorganization, merger, recapitalization, reclassification,
stock split, stock dividend, stock consolidation, or otherwise, an appropriate
and proportionate adjustment shall be made in the number and kind of shares as
to which options may be granted. A corresponding adjustment changing the number
or kind of shares and the exercise price per share allocated to unexercised
options, or portions thereof, which shall have been granted prior to any such
change shall likewise be made. Any such adjustment, however, in an outstanding
option shall be made without change in the total price applicable to the
unexercised portion of the option but with a corresponding adjustment in the
price for each share subject to the option. Adjustments under this section shall
be made by the Committee, whose determination as to what adjustments shall be
made, and the extent thereof, shall be final and conclusive. No fractional
shares of stock shall be issued under the 2002 Non-Qualified Plan on account of
any such adjustment.
10. TERMINATING EVENT.
Not less than thirty (30) days prior to the dissolution or liquidation of
the Company, or a reorganization, merger or consolidation of the Company with
one or more corporations as a result of which the Company will not be the
surviving or resulting corporation, or a sale of substantially all the assets of
the Company to another person, or a reverse merger in which the Company is the
surviving corporation but the shares of the Company's stock outstanding
immediately preceding the merger are converted by virtue of the merger into
other property, or in the event of any other capital reorganization or in which
shares of stock of the Company possessing more than fifty percent (50%) of the
voting power of the Company are exchanged (a "Terminating Event"), the Committee
shall notify each optionee of the pendency of the Terminating Event. Upon
delivery of said notice, any option granted prior to the Terminating Event shall
be, notwithstanding the provisions of paragraph 5 hereof, exercisable in full
and not only as to those shares with respect to which installments, if any, have
then accrued, subject, however, to earlier expiration or termination as provided
elsewhere in the 2002 Non-Qualified Plan. Upon the date thirty (30) days after
delivery of said notice, any option or portion thereof not exercised shall
terminate, and upon the effective date of the Terminating Event, the 2002
Non-Qualified Plan shall terminate, unless provision is made in connection with
the Terminating Event for assumption of options theretofore granted, or
substitution for such options of new options covering stock of a successor
employer corporation, or a parent or subsidiary corporation thereof, solely at
the option of such successor corporation or parent or subsidiary corporation,
with appropriate adjustments as to number and kind of shares and prices.
Formation of a holding company for the Company in which the shareholders of the
holding company after its formation are substantially the same as for the
Company prior to the holding company formation shall not be a Terminating Event.
11. AMENDMENT OF THE 2002 NON-QUALIFIED PLAN.
(a) The Committee at any time, and from time to time, may amend the 2002
Non-Qualified Plan, PROVIDED, HOWEVER, that the provisions of paragraph 12 shall
not be amended more than once every three (3) months, other than to comport with
changes in the Internal Revenue Code, the Employee Retirement Income Security
Act or the rules thereunder. Except as provided in paragraph 9 relating to
adjustments upon changes in stock, no amendment shall be effective unless within
twelve (12) months before or after the adoption of the amendment, by the vote of
a majority of the shares of the company represented and voting at a shareholders
meeting or by the written consent of a majority of the outstanding shares of the
Company where the amendment will:
(i) Increase the number of shares reserved for options under the 2002
Non-Qualified Plan;
(ii) Materially modify the requirements as to eligibility for participation
in the 2002 Non-Qualified Plan; or
(iii) Materially increase the benefits accruing to participants under the
2002 Non-Qualified Plan.
(b) Rights and obligations under any option granted pursuant to the 2002
Non-Qualified Plan shall not be altered or impaired by amendment of the 2002
Non-Qualified Plan, except with the consent of the person to whom the stock or
option was granted.
12. TERMINATION, SUSPENSION AND LIMITATIONS OF THE 2002 NON-QUALIFIED PLAN.
(a) The Committee may suspend or terminate the 2002 Non-Qualified Plan at
any time. Unless sooner terminated, the 2002 Non-Qualified Plan shall terminate
ten years from the effective date of the 2002 Non-Qualified Plan. No options may
be granted under the 2002 Non-Qualified Plan while the 2002 Non-Qualified Plan
is suspended or after it is terminated.
(b) Rights and obligations under any option granted pursuant to the 2002
Non-Qualified Plan while the 2002 Non-Qualified Plan is in effect shall not be
altered or impaired by suspension or termination of the 2002 Non-Qualified Plan.
(c) Notwithstanding any other provision of this Plan, no option may be
granted hereunder that by its terms may be exercised beyond the time that is ten
(10) years from its date of grant by the Company.
13. EFFECTIVE DATE OF PLAN.
The 2002 Non-Qualified Plan shall become effective as of October 22, 2002.
Exhibit 4(b)
Raymond James & Associates, Inc.
Rule 10b5-1 Sales Trading Plan
(Non-discretionary Plan-Owned Shares Only)
Use this version of the Sales Plan if the seller wishes to indicate the
amount, price and date of stock sales with such specificity that Raymond James
will not have any discretion over how, when and whether to sell stock (other
than the discretion inherent in applying ordinary principles of best execution).
,("Seller") hereby adopts this Sales Plan dated October , 2007 ("Sales Plan")
between Seller and Raymond James & Associates, Inc. ("Raymond James"), acting as
agent.
Recital
This Sales Plan is being entered into between Seller and Raymond James to
establish a trading plan for Seller that complies with the requirements of Rule
10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended (the
"Exchange Act"). Seller is establishing this Sales Plan to dispose of all or a
portion of Seller's holdings of the [common stock], [par value $[ ] per share]
[no par value] (the "Stock"), of [name of issuer] (the "Issuer").
A. Implementation of the Plan
1. Seller hereby appoints Raymond James to sell shares of Stock pursuant to
the terms and conditions set forth below. Subject to such terms and conditions,
Raymond James hereby accepts such appointment.
2. Raymond James is authorized to begin selling Stock pursuant to this
Sales Plan on ___________________, 200___ (which shall be no earlier than ___
days from the date this Sales Plan is adopted) and shall cease selling Stock on
the earliest to occur of the date on which Raymond James receives notice of the
death of Seller, as soon as reasonably practical after learning that the Issuer
or any other person publicly announces a tender or exchange offer with respect
to the Stock, the date of public announcement of a merger, acquisition,
reorganization, recapitalization or comparable transaction affecting the
securities of the Issuer as a result of which the Stock is exchanged or
converted into shares of another company, the date on which Raymond James
receives notice of the commencement of any proceedings in respect of or
triggered by Seller's bankruptcy or insolvency and (specify one or more
occurrences that will mark the last day on which sales may occur):
________________, 200___; and the date that an aggregate of _______ shares of
Stock are sold pursuant to this Sales Plan; and the date that the aggregate
proceeds of sales pursuant to this Sales Plan (after deducting commissions and
other expenses of sale reaches $___________. (the "Plan Sales Period").
3. (a) Raymond James shall sell the Daily Sale Amount (as defined below)
for the account of Seller on each Sale Day (as defined below), subject to the
following restrictions, if desired: Raymond James shall not sell any shares of
Stock pursuant to this Sales Plan at a price of less than $ __________per share
(before deducting commissions and other expenses of sale) (the "Minimum Sale
Price"). (insert other restrictions, if any) ___________________________.
(b) A "Sale Day" is (specify the days on which Raymond James is to sell
Stock, e.g., "each Trading Day," "the first Monday of each month" or "the first
Trading Day immediately succeeding any period of five consecutive Trading Days
during which the market price of the Stock on each Trading Day was equal to or
greater than $25") ______________________________________ during the Plan Sales
Period, provided that if any Sale Day is not a Trading Day, such Sale Day shall
be deemed to fall on the next succeeding Trading Day. A "Trading Day" is any day
during the Plan Sales Period that the [name of principal market or exchange for
the Stock] (the "Principal Market") is open for business and the Stock trades
regular way on the Principal Market.
(c) The "Daily Sale Amount" for any Sale Day shall be (please check the
applicable box to indicate the amount of Stock that Raymond James is to sell on
each Sale Day): _____________ shares of Stock. an amount of Stock resulting in
aggregate proceeds (after deducting commissions and other expenses of sale of
$________________. determined in accordance with the following formula:
(1) he amount set forth on the grid below opposite the per share price
range that corresponds to the reported price of the opening reported market
transaction in the Stock on such Sale Day.
--------------------------------------------------------------------------------
-------------------------------------- Reported Price of Opening Reported Market
Transaction in the Stock Daily Sale Amount
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
-------------------------------------- If the price is below
$______________________
--------------------------------------------------------------------------------
--------------------------------------
--------------------------------------------------------------------------------
If the price is between $_______ and $________
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
-------------------------------------- If the price is between $_______ and
$________
--------------------------------------------------------------------------------
--------------------------------------
--------------------------------------------------------------------------------
If the price is above $_____________________.
(d) Subject to the restrictions set forth in paragraph A.3(a) above,
Raymond James shall sell the Daily Sale Amount on each Sale Day under ordinary
principles of best execution at the then-prevailing market price.
(e) If, consistent with ordinary principles of best execution or for any
other reason, Raymond James cannot sell the Daily Sale Amount on any Sale Day,
then (select one): the amount of such shortfall may be sold as soon as
practicable on the immediately succeeding Trading Day under ordinary principles
of best execution; provided that in no event may the amount of the shortfall for
any such Sale Day be sold later than the fourth business day after such Sale
Day. Raymond James's obligation to sell Stock on such Sale Day pursuant to this
Sales Plan shall be deemed to have been satisfied. Nevertheless, if any such
shortfall exists after the close of trading on the last Trading Day of the Plan
Sales Period, Raymond James's authority to sell such shares for the account of
Seller under this Sales Plan shall terminate.
(f) The Daily Sale Amount and the Minimum Sale Price, if applicable, shall
be adjusted automatically on a proportionate basis to take into account any
stock split, reverse stock split or stock dividend with respect to the Stock or
any change in capitalization with respect to the Issuer that occurs during the
Plan Sales Period.
4. Raymond James shall not sell Stock hereunder at any time when:
(i) Raymond James, in its sole discretion, has determined that a market
disruption, banking moratorium, outbreak or escalation of hostilities or other
crisis or calamity has occurred; or
(ii) Raymond James, in its sole discretion, has determined that it is
prohibited from doing so by a legal, contractual or regulatory restriction
applicable to it or its affiliates or to Seller or Seller's affiliates (other
than any such restriction relating to Seller's possession or alleged possession
of material nonpublic information about the Issuer or the Stock); or
(iii) Raymond James has received notice from the Issuer or Seller of the
occurrence of any event contemplated by paragraph 3 of the certificate set forth
as Exhibit A hereto; or
(iv) Raymond James has received notice from Seller to terminate the plan in
accordance with paragraph C.1 below.
5. (a) Seller has delivered the Stock to be sold pursuant to this Sales
Plan (with the amount to be estimated by Seller in good faith, if the Daily Sale
Amount is designated as an aggregate dollar amount) (the "Plan Shares") into an
account at Raymond James in the name of and for the benefit of Seller (the "Plan
Account").
(b) Raymond James shall withdraw Stock from the Plan Account in order to
effect sales of Stock under this Sales Plan. If at any time during the Plan
Sales Period the number of shares of Stock in the Plan Account is less than the
number of Plan Shares remaining to be sold pursuant to this Sales Plan, Raymond
James shall have no further obligation to effect sales of Shares under this
Sales Plan.
(c) To the extent that any Stock remains in the Plan Account after the end
of the Plan Sales Period or upon termination of this Sales Plan, Raymond James
agrees to return such Stock promptly to the Seller.
6. Raymond James shall in no event effect any sale under this Sales Plan if
the Stock to be sold is not in the Plan Account.
7. Raymond James may sell Stock on any national securities exchange, in the
over-the-counter market, on an automated trading system or otherwise.
B. Seller's Representations, Warranties and Covenants. Seller hereby
represents, warrants and covenants that:
1. Seller is not aware of any material nonpublic information concerning the
Issuer or its securities. Seller is entering into this Sales Plan in good faith
and not as part of a plan or scheme to evade compliance with the federal
securities laws.
2. The securities to be sold under this Sales Plan are owned free and clear
by Seller [(subject, in the case of shares underlying Options, only to the
compliance by Seller with the exercise provisions of such Options)] and are not
subject to any liens, security interests or other encumbrances or limitations on
disposition other than those imposed by Rules 144 or 145 under the Securities
Act of 1933, as amended (the "Securities Act").
3. While this Sales Plan is in effect, Seller agrees not toenter into or
alter any corresponding or hedging transaction or position with respect to the
securities covered by this Sales Plan and agrees, except as expressly permitted
herein, not to alter or deviate from the terms of this Sales Plan.
4. (a) Seller has provided Raymond James with a certificate dated as of the
date hereof signed by the Issuer substantially in the form of Exhibit A hereto.
(b) Seller agrees to notify Raymond James's credit department by
telephone at the number set forth in paragraph F.5 below as soon as practicable
if Seller becomes aware of the occurrence of any event contemplated by paragraph
3 of the certificate set forth as Exhibit A hereto. Such notice shall indicate
the anticipated duration of the restriction, but shall not include any other
information about the nature of the restriction or its applicability to Seller
and shall not in any way communicate any material nonpublic information about
the Issuer or its securities to Raymond James. Such notice shall be in addition
to the notice required to be given to Raymond James by the Issuer pursuant to
the certificate set forth as Exhibit A hereto.
5. The execution and delivery of this Sales Plan by Seller and the
transactions contemplated by this Sales Plan will not contravene any provision
of applicable law or any agreement or other instrument binding on Seller or any
of Seller's affiliates or any judgment, order or decree of any governmental
body, agency or court having jurisdiction over Seller or Seller's affiliates.
6. Seller agrees that until this Sales Plan has been terminated as
permitted herein Seller shall not (i) enter into a binding contract with respect
to the purchase or sale of Stock with another broker, dealer, financial
institution or other party (each, a "Financial Institution"), (ii) instruct
another Financial Institution to purchase or sell Stock or (iii) adopt a plan
for trading with respect to Stock other than this Sales Plan.
7. Seller agrees that it shall not, directly or indirectly, communicate any
material nonpublic information relating to the Stock or the Issuer to any
employee of Raymond James or its affiliates who is involved, directly or
indirectly, in executing this Sales Plan at any time while this Sales Plan is in
effect.
8. Seller agrees that Seller shall at all times during the Plan Sales
Period (as defined below), in connection with the performance of this Sales
Plan, comply with all applicable laws, including, without limitation, Section 16
of the Exchange Act and the rules and regulations promulgated thereunder, and
make all filings, if any, required under Sections 13(d), 13(g) and 16 of the
Exchange Act in a timely manner, to the extent any such filings are applicable
to Seller.
9. (a) Seller represents and warrants that the Stock to be sold pursuant to
this Sales Plan is currently eligible for sale under Rule 144 or 145.
(b) Seller agrees not to take, and agrees to cause any person or entity
with which Seller would be required to aggregate sales of Stock pursuant to
paragraph (a)(2) or (e) of Rule 144 not to take, any action that would cause the
sales hereunder not to meet all applicable requirements of Rule 144.
(c) Seller agrees to complete, execute and deliver to Raymond James Forms
144 for the sales to be effected under this Sales Plan at such times and in such
numbers as Raymond James shall request, and Raymond James agrees to file such
Forms 144 on behalf of Seller as required by applicable law. Seller understands
and agrees that Raymond James shall make one Form 144 filing at the beginning of
each three-month period commencing upon the first Sale Day under this Sales
Plan.
(d) Seller hereby grants Raymond James a power of attorney to complete
and/or file on behalf of Seller any required Forms 144. Notwithstanding such
power of attorney, Seller acknowledges that Raymond James shall have no
obligation to complete or file Forms 144 on behalf of Seller except as set forth
in subparagraph (c).
(e) Raymond James agrees to conduct all sales pursuant to this Sales Plan
in accordance with the manner of sale requirement of Rule 144 of the Securities
Act and in no event shall Raymond James effect any sale if such sale would
exceed the then-applicable amount limitation under Rule 144, assuming Raymond
James's sales pursuant to this Sales Plan are the only sales subject to that
limitation.](3)
10. Seller acknowledges and agrees that Seller does not have, and shall not
attempt to exercise, any influence over how, when or whether to effect sales of
Stock pursuant to this Sales Plan.
11. Raymond James may sell Stock on any national securities exchange, in
the over the counter market, on an automated trading system or otherwise.
Raymond James or one of its affiliates may make a market in the Stock and may
act as principal in executing sales under the Trading Plan. To the extent that
Raymond James administers other trading plans relating to Issuer's securities,
Raymond James may aggregate orders for Seller with orders under other sellers'
trading plans for execution in a block and allocate each execution on a pro rata
basis to each seller. In the event of partial execution of block orders, Raymond
James shall allocate the proceeds of all Stock actually sold on a particular day
pursuant to all Rule 10b5-1 trading plans concerning issuer's securities that
Raymond James manages pro rata based on the ratio of (x) the number of shares to
be sold pursuant to the order instructions of each Trading Plan to (y) the total
number of shares to be sold under all Trading Plans having the same type of
order instructions.
C. Termination
1. This Sales Plan may not be terminated prior to the end of the Plan Sales
Period, except that:
(i) it may be terminated at any time by written notice from Seller received
by Raymond James's credit department at the address or fax number set forth in
paragraph F.5 below for any reason as long as such termination is made in good
faith and not as part of a plan or scheme to evade the insider trading rules and
Seller represents that to Raymond James in such notice; with reasons for a
permitted termination including where legal or regulatory restrictions
applicable to Seller or Seller's affiliates (other than any such restrictions
relating to Seller's possession or alleged possession of material nonpublic
information about the Issuer or the Stock) would prevent Raymond James from
selling Stock for Seller's account during the Plan Sales Period, and
(ii) it may be suspended or, at Raymond James's option, terminated if
Raymond James has received notice from the Issuer of the occurrence of any event
contemplated by paragraph 3 of the certificate set forth as Exhibit A hereto.
D. Indemnification; Limitation of Liability
1.(a) Seller agrees to indemnify and hold harmless Raymond James and its
directors, officers, employees and affiliates from and against all claims,
losses, damages and liabilities (including, without limitation, any legal or
other expenses reasonably incurred in connection with defending or investigating
any such action or claim) arising out of or attributable to Raymond James's
actions taken or not taken in compliance with this Sales Plan or arising out of
or attributable to any breach by Seller of this Sales Plan (including Seller's
representations and warranties hereunder) or any violation by Seller of
applicable laws or regulations. This indemnification shall survive termination
of this Sales Plan.
(b) Notwithstanding any other provision hereof, Raymond James shall not be
liable to Seller for:
(i) special, indirect, punitive, exemplary or consequential damages, or
incidental losses or damages of any kind, even if advised of the possibility of
such losses or damages or if such losses or damages could have been reasonably
foreseen; or
(ii) any failure to perform or to cease performance or any delay in
performance that results from a cause or circumstance that is beyond its
reasonable control, including but not limited to failure of electronic or
mechanical equipment, strikes, failure of common carrier or utility systems,
severe weather, market disruptions or other causes commonly known as "acts of
God".
(c) Notwithstanding any other provision hereof, Raymond James shall not be
liable to Seller for
(i) the exercise of discretionary authority or discretionary control under
this Trading Plan, if any, or
(ii)any failure to effect a sale required by paragraph A, except for
failures to effect sales as a result of the gross negligence or willful
misconduct of Raymond James.
2. Seller has consulted with Seller's own advisors as to the legal, tax,
business, financial and related aspects of, and has not relied upon Raymond
James or any person affiliated with Raymond James in connection with, Seller's
adoption and implementation of this Sales Plan.
3. Seller acknowledges and agrees that in performing Seller's obligations
hereunder neither Raymond James nor any of its affiliates nor any of their
respective officers, employees or other representatives is exercising any
discretionary authority or discretionary control respecting management of
Seller's assets, or exercising any authority or control respecting management or
disposition of Seller's assets, or otherwise acting as a fiduciary (within the
meaning of Section 3(21) of the Employee Retirement Income Security Act of 1974,
as amended, or Section 2510.3-21 of the Regulations promulgated by the United
States Department of Labor) with respect to Seller or Seller's assets. Without
limiting the foregoing, Seller further acknowledges and agrees that neither
Raymond James nor any of its affiliates nor any of their respective officers,
employees or other representatives has provided any "investment advice" within
the meaning of such provisions, and that no views expressed by any such person
will serve as a primary basis for investment decisions with respect to Seller's
assets.
E. Agreement to Arbitrate The arbitration provisions of the Raymond James
Client Agreement are incorporated by reference.
F. General
1. Seller shall pay Raymond James $[ ] per share of the Stock sold.
2. Seller and Raymond James acknowledge and agree that this Sales Plan is a
"securities contract," as such term is defined in Section 741(7) of Title 11 of
the United States Code (the "Bankruptcy Code"), entitled to all of the
protections given such contracts under the Bankruptcy Code.
3. This Sales Plan constitutes the entire agreement between the parties
with respect to this Sales Plan and supersedes any prior agreements or
understandings with regard to the Sales Plan.
4. This Sales Plan may be amended by Seller only upon the written consent
of Raymond James and receipt by Raymond James of the following documents, each
dated as of the date of such amendment:
(i) a representation signed by the Issuer substantially in the form of
Exhibit A hereto, and
(ii) a certificate signed by Seller certifying that the representations and
warranties of Seller contained in this Sales Plan are true at and as of the date
of such certificate as if made at and as of such date.
5. All notices to Raymond James under this Sales Plan shall be given to
Raymond James's credit department in the manner specified by this Sales Plan by
confirmed facsimile to (___) ___-____ (attn:
_________________________________________) or by certified mail to the address
below: ________________________________ ________________________________
________________________________ Attn.: ___________________________
6. Seller's rights and obligations under this Sales Plan may not be
assigned or delegated without the written permission of Raymond James.
7. This Sales Plan may be signed in any number of counterparts, each of
which shall be an original, with the same effect as if the signatures thereto
and hereto were upon the same instrument.
8. If any provision of this Sales Plan is or becomes inconsistent with any
applicable present or future law, rule or regulation, that provision will be
deemed modified or, if necessary, rescinded in order to comply with the relevant
law, rule or regulation. All other provisions of this Sales Plan will continue
and remain in full force and effect.
9. This Sales Plan shall be governed by and construed in accordance with
the internal laws of the State of New York and may be modified or amended only
by a writing signed by the parties hereto. NOTICE: THIS AGREEMENT CONTAINS A
PRE-DISPUTE ARBITRATION CLAUSE IN PARAGRAPH E. IN WITNESS WHEREOF, the
undersigned have signed this Sales Plan as of the date first written above.
[Name of Seller] ______________________________________ RAYMOND JAMES &
ASSOCIATES, INC. By: ___________________________________ Name: Title:
EXHIBIT A
ISSUER REPRESENTATION
1. [Name of Issuer] (the "Issuer") represents that it has approved the
Sales Plan dated ____________________________, 200_ (the "Sales Plan") between
[Name of Seller] ("Seller") and Raymond James & Associates, Inc. ("Raymond
James") relating to the [common stock], [par value $[ ] per share] [no par
value] of the Issuer (the "Stock").
2. The sales to be made by Raymond James for the account of Seller pursuant
to the Sales Plan will not violate the Issuer's insider trading policies, and to
the best of the Issuer's knowledge there are no legal, contractual or regulatory
restrictions applicable to Seller or Seller's affiliates as of the date of this
representation that would prohibit either Seller from entering into the Sales
Plan or any sale pursuant to the Sales Plan.
3. If, at any time during the Plan Sales Period, the Issuer becomes aware
of legal, contractual or regulatory restriction that is applicable to Seller or
Seller's affiliates would prohibit any sale pursuant to the Sales Plan (other
than any such restriction relating to Seller's possession or alleged possession
of material nonpublic information about the Issuer or its securities), the
Issuer agrees to give Raymond James's credit department notice of such
restriction by telephone as soon as practicable. Such notice shall be made to
the ______________ __________________________ at (___) ___-____ and shall
indicate the anticipated duration of the restriction, but shall not include any
other information about the nature of the restriction or its applicability to
Seller. In any event, the Issuer shall not communicate any material nonpublic
information about the Issuer or its securities to Raymond James.
Dated: ____________________, 200__
[NAME OF ISSUER]
By: ______________________________
Name:
Title:
(1) This formula, together with the other provisions of this Section 3,
must identify the amount, price and date of sales with the specificity required
by Rule 10b5-1(c)(1)(i)(B)(2).
(2) The Seller's representation on the Forms 144 regarding Seller's
knowledge of material information regarding the Issuer may be made as of the
date this Sales Plan is adopted. The "Remarks" section of each Form 144 should
state that the sale is being made pursuant to a previously adopted plan intended
to comply with Rule 10b5-1(c) and indicate the date the Sales Plan was adopted
and that the representation is made as of such date.
(3) Include paragraph 9 if the Stock is to be sold under Rule 144 or 145.
Exhibit 23(a)
CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Ocean Bio-Chem,
Inc.'s Registration Statement on Form S-8 of our report dated March 21, 2007
relating to the consolidated financial statements which appear in Ocean
Bio-Chem, Inc.'s Annual Report on Form 10-K for the year ended December 31,
2006, filed with the Securities and Exchange Commission and to all references to
our firm included in this Registration Statement. We also consent to the
reference to us under the heading "Experts" in such Registration Statement.
Berenfeld, Spritzer, Shechter & Sheer
Fort Lauderdale, Florida
October 22, 2007
Exhibit 23(b)
CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Ocean Bio-Chem,
Inc.'s Registration Statement on Form S-8 of our report dated March 22, 2007
relating to the consolidated financial statements for the years ended December
31, 2005 and 2004 which appear in Ocean Bio-Chem, Inc.'s Annual Report on Form
10-K for the year ended December 31, 2006, filed with the Securities and
Exchange Commission and to all references to our firm included in this
Registration Statement. We also consent to the reference to us under the heading
"Experts" in such Registration Statement.
Levi & Gopman, P.A. (formally known as Levi Cahlin & Co).
North Miami Beach, Florida
October 22, 2007